Results for "Understanding Pharmaceutical Distribution"
How Distributors Facilitate Patient Access to Specialty Therapies
Specialty pharmaceuticals — complex medications that require special handling, administration and ongoing clinical support — are reshaping healthcare delivery. These therapies offer hope for patients living with serious or chronic conditions; however, specialty medications are also introducing unprecedented complexity in how products are being manufactured, transported and accessed.
HDA Statement on FDA Distributor Licensure Proposed Rule
The Healthcare Distribution Alliance (HDA) released the following statement from President and CEO Chester “Chip” Davis Jr., regarding FDA’s proposed rule, issued as required by the Drug Supply Chain Security Act (DSCSA), entitled “National Standards for Licensure of Wholesale Drug Distributors and Third-Party Logistics Providers.”
HDA Applauds Senate Passage of Maryland Legislation Designed To Clarify Role of Critical Pharmacy Partners
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the passage of SB 823 by the Maryland Senate.
Governor Hogan's Signing of Maryland Law Affirms Critical Role of PSAOs and Support for Independent Pharmacies
The Healthcare Distribution Alliance (HDA) issued the following statement today from President and CEO Chester “Chip” Davis, Jr., regarding the signing of SB 823 by Maryland Governor Larry Hogan.
HDA Statement on National Biodefense Strategy and Implementation Plan
The Healthcare Distribution Alliance (HDA) released the following statement in response to the Biden-Harris administration’s National Biodefense Strategy and Implementation Plan.